July 13, 2026

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

Genflow Biosciences reported positive interim and three-month follow-up results from its SLAB canine trial, expanded animal health partnerships, secured a fully funded LNP collaboration with Acuitas Therapeutics and strengthened its..

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

Real Estate Credit Investments maintained its 3p quarterly dividend, offering a 10.3% yield, while outlining routes to restore dividend cover. Credit performance remains strong, leverage is conservative and the shares..

RM Assessment targets expanding demand for digital exams

RM Assessment is positioned to benefit as schools and awarding bodies adopt more digital and hybrid examination systems...

Drax takes control of Aldi’s UK EV charging network

Drax will operate and expand around 1,200 electric vehicle chargers across Aldi’s UK store network...

Energy strength and resilient trading updates support the FTSE 100

Higher oil prices and resilient company updates supported a steadier outlook for the FTSE 100...

AI leadership gives emerging markets a stronger strategic position

Emerging markets are gaining a more important role in the global artificial intelligence economy, led by major Asian semiconductor companies with strong positions in advanced computing infrastructure...

Oriole Resources’s CFO outlines next steps at Mbe, Senala, and Bibemi (LON:ORR)

Oriole Resources CFO Bob Smeeton discusses partner-funded drilling at Senala and the company’s wider plans to advance its gold assets in Senegal and Cameroon...

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating a Stable Path in Biotechnology

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company focused on developing treatments for rare diseases, is drawing investor attention with its consistent market positioning and intriguing financial metrics. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 87% Upside Potential in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) is making waves in the biotechnology sector, attracting investor attention with its promising vaccine pipeline and notable upside potential. With an impressive market capitalization of $8.41..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Investors Eye Potential 18.29% Upside in CNS Drug Innovator

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has captured the attention of investors with its promising pipeline of novel therapies targeting central nervous system (CNS) disorders, a sector that continues to see..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth Potential with a 4.61% Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a current market capitalization of $3.18 billion. As..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Powerhouse with 27% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) has emerged as a formidable contender in the biotechnology sector, with its innovative approach to muscle activators and inhibitors. With a market capitalization of $11.52 billion,..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Unpacking a 26.46% Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL) is making waves in the biotechnology sector, particularly within the niche of metabolic dysfunction-associated steatohepatitis (MASH), a condition with significant unmet medical needs. Based in West..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 49.45% Upside for Healthcare Investors

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, is drawing investor attention with a compelling potential upside of 49.45%. Headquartered in Barcelona, Spain, Grifols specializes in..

Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX) stands as a formidable entity in the healthcare sector, specializing in the development and supply of single-use medical devices. With a market capitalization of $6.01 billion,..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Is the Current Valuation Justified Amidst Strong Revenue Growth?

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, specializes in providing vital clinical research-based services for drug and medical device development across the globe. With a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 28.91% Upside Potential in Biotechnology

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its focus on tackling rare neuroendocrine diseases. Based in Boston, Massachusetts, this commercial-stage biopharmaceutical company has garnered..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 21.93% Upside Potential Beckons Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out in the healthcare sector, specifically in the medical instruments and supplies industry, with a robust market capitalization of $4.38 billion. This U.S.-based..

Waystar Holding Corp. (WAY) Stock Analysis: Unveiling a 49.64% Potential Upside

For investors eyeing the healthcare sector, Waystar Holding Corp. (WAY) presents an intriguing opportunity. This Lehi, Utah-based company specializes in health information services, offering a robust cloud-based software solution that..

Oscar Health, Inc. (OSCR) Stock Analysis: Evaluating Growth Potential Amidst a Robust 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR) has emerged as a notable player in the healthcare technology sector, captivating investor interest due to its impressive revenue growth and innovative approach to healthcare..

Search

Funds

July 13, 2026

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

Genflow Biosciences reported positive interim and three-month follow-up results from its SLAB canine trial, expanded animal health partnerships, secured a fully funded LNP collaboration with Acuitas Therapeutics and strengthened its SIRT6 patent portfolio...

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

Real Estate Credit Investments maintained its 3p quarterly dividend, offering a 10.3% yield, while outlining routes to restore dividend cover. Credit performance remains strong, leverage is conservative and the shares continue to trade at a substantial discount to NAV...

RM Assessment targets expanding demand for digital exams

RM Assessment is positioned to benefit as schools and awarding bodies adopt more digital and hybrid examination systems...

Drax takes control of Aldi’s UK EV charging network

Drax will operate and expand around 1,200 electric vehicle chargers across Aldi’s UK store network...

Energy strength and resilient trading updates support the FTSE 100

Higher oil prices and resilient company updates supported a steadier outlook for the FTSE 100...

AI leadership gives emerging markets a stronger strategic position

Emerging markets are gaining a more important role in the global artificial intelligence economy, led by major Asian semiconductor companies with strong positions in advanced computing infrastructure...

Oriole Resources’s CFO outlines next steps at Mbe, Senala, and Bibemi (LON:ORR)

Oriole Resources CFO Bob Smeeton discusses partner-funded drilling at Senala and the company’s wider plans to advance its gold assets in Senegal and Cameroon...
Search

Funds

July 13, 2026

FTSE 100

Funds